Healthcare disrupter Haven recruiting replacement for Gawande

Just six months after Haven pilot-tested its initial health-benefits plans, Atul Gawande, MD, MPH, is relinquishing his role as the fledgling organization’s CEO.

The renowned surgeon and bestselling author will stay on as chairman, focusing on advocacy and policy tasks while tending to fewer day-to-day operational matters, the Wall Street Journal is reporting.

Haven launched in early 2018 with a high-visibility PR campaign. Gawande was handpicked by tycoons Jeff Bezos, Warren Buffet and Jamie Dimon to lead the endeavor.

Its stated aim was—and presumably still is—to “transform healthcare to create better outcomes and overall experience, as well as lower costs for you and your family.”

Despite the initial hype, “the venture’s efforts so far have been of limited scope,” WSJ notes, adding that Gawande’s hiring “was seen as a signal that the partners’ ambitions were set higher than conventional tweaks to health coverage.”

Sources close to the development tell the newspaper Haven has launched a search for a new CEO but has yet to settle on a candidate and hasn’t made a decision on its leadership structure going forward.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.